We found that IDH-mutant specimens contained fewer intratumoral M2-like macrophages and myeloid-derived suppressor cells (MDSCs) than their wildtype counterparts, and that this phenomenon could be reproduced in mice by introducing the IDH-mutant enzyme into murine glioma models. Here, IDH1 is linked to central nervous system cancer.